Logo.png
Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis, Alladapt Immunotherapeutics, Regeneron Pharmaceuticals, Genentech, Parexel
26 mars 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, March 26, 2024 (GLOBE NEWSWIRE) -- Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis,...
Logo.png
Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
25 mars 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, March 25, 2024 (GLOBE NEWSWIRE) -- Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The rise in the number of people suffering from cirrhosis can be...
Logo.png
PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain
21 mars 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, March 21, 2024 (GLOBE NEWSWIRE) -- PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the...
Logo.png
Bronchiolitis Obliterans Syndrome Market to Grow Substantially by 2032, Assesses DelveInsight | Key Players - OrphAI Therapeutics, Sanofi, Renovion, Zambon SpA, Mallinckrodt, Incyte Corporation, GlaxoSmithKline, Mereo Biopharma, Genentech
29 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bronchiolitis Obliterans Syndrome Market to Grow Substantially by 2032, Assesses DelveInsight | Key Players - OrphAI Therapeutics, Sanofi, Renovion,...
Logo.png
Vasomotor Symptoms Market is Likely to Increase at a Steady Growth Rate by 2034, Estimated DelveInsight | Key Companies - Estetra, Bayer, Hansoh BioMedical R&D Company, Mitsubishi Tanabe Pharma, Astellas Pharma Inc
28 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Vasomotor Symptoms Market is Likely to Increase at a Steady Growth Rate by 2034, Estimated DelveInsight | Key Companies - Estetra, Bayer, Hansoh...
Logo.png
Dup15q Syndrome Drug Market is Projected to Grow Significantly During the Study Period (2019–2032) | DelveInsight
27 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Dup15q Syndrome Drug Market is Projected to Grow Significantly During the Study Period (2019–2032) | DelveInsight  An increase in the prevalence,...
Logo.png
Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene Therapeutics, Pfizer, Genentech, Incyte Corporation, Bristol-Myers Squibb
26 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene...
Logo.png
Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight
22 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight   The dynamics of the short...
Logo.png
Ascites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsight
21 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ascites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsight  The rise in the patient population of ascites, the...
Logo.png
PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight
20 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight   The PD-1 and PD-L1 inhibitor...